Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502603 · ClinicalTrials.gov registry record · NA
Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03502603 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 137 participants.
The verdict
NCT03502603, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests will be assessed with regard to reliability and validity. Reliability will be addressed through investigation of internal consistency of the test items. Validity will be evaluated relative to traditional paper-and-pencil tests and differentiation between patient and healthy participants.Each participant will complete both the computerized and paper and pencil-based tests. The results will be analyzed to see how performances on the two test types compare. The overall aim of this project is to determine if these new computerized tasks are an improvement over standard paper and pencil-based neuropsychological measures.
Interventions
- DIAGNOSTIC_TEST Railroad Test
- DIAGNOSTIC_TEST Swamp Test
- DIAGNOSTIC_TEST Presidents Recognition Test
- DIAGNOSTIC_TEST Judgment of Line Orientation
- DIAGNOSTIC_TEST Symbol Span subtest of the Wechsler Memory Scale-IV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2023-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502603
The ClinicalTrials.gov registry entry for NCT03502603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Railroad Test is the first listed.
NCT03502603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03502603 about?
NCT03502603 is a clinical study titled "Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses". This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests ...
What is the current status of trial NCT03502603?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2019-05-10. Estimated completion is 2023-12-06.
What interventions are being tested in trial NCT03502603?
The interventions under investigation include: Railroad Test (DIAGNOSTIC_TEST), Swamp Test (DIAGNOSTIC_TEST), Presidents Recognition Test (DIAGNOSTIC_TEST), Judgment of Line Orientation (DIAGNOSTIC_TEST), Symbol Span subtest of the Wechsler Memory Scale-IV (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03502603?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.